1Laterza OF, P rieeCP, ScottMG,et al. Cystatin C: an improved estimator of g102 merular filtration rate? Clin Chem, 2002, 48 (5) : 699 - 707.
2Dharnidharka VR, Kwon G, Stevens G. Serum eystatin C is superior to serum creatinine as a marker of kidney function : a meta analysis. Am J Kidney Dis,2002,40 : 221 - 227.
3Lindhoh JS, Erlandsen EJ , Henneberg EW. Cystatin C defteieney is associated with the progression of small abdominal aortic aneurysms. Br J Surg, 2001,88:1 472 - 1 475.
4Shi GP, Sukhova GK, Grubb A, et al. Cystatin C deficiencyin hunlanatherosclcrosis and aortic aneurysms. J Clin Invest, 1999,104:1 191 -1 197.
5Sukhova GK, Wang B, Libby P,et al. Cystatin C deficiency increases elastic lamina degradation and aortic dilalation in apo - lipoprolein E - null mice. Circ Res ,2005,96( 3 ) :368- 375.
6Luc G, Bard JM, Lesueur C, et al. Plasma cvstatin C and development of coronary, heart disease: The PRIME Study. Atherosc.lerosis, 2006,85 ( 2 ) :375 - 380.
8Jernberg T, Lindahl B, James S,et al. Cystatin C:a novel predictor of outcome in suspected or confirmed non - st elevation acute coronary syndrome. Circulation, 2004, 110 : 2 342 -2 348.
9Noto D, Cefalu'AB, Barbagallo CM,et al. Cystatin C levels are decreased in acute myocardial infarction, effect of cystatin C G73A gene polymorphism on plasma levels. Int J Cardiol, 2005,101(2) :213 -217.
10Ichimoto E, Jo K, Kobayashi Y, et al. P rogmostic sign ificance of cystatin C in patients with ST2eleva tionmyocardial infarction. Circ J, 2009, 73(9) : 1 669 - 1 673.
2McMahan CA,Gidding SS,McGill HC. Coronary heart disease risk factors and atherosclerosis in young people[J]. J Clin Lipidol,2008,2(3) : 118-126.
3Simonsen O,Grubb A,Thysell H. The blood serum concentration of Cystatin C (gamma-trace)as a measure of the glomerular filtration rate [J]. Scand J Clin Lab Invest, 1985,45 (2) :97-101.
4Koenig W,Twardella D, Brenner H, et al. Plasma concentration of cystatin c in patients with coronary heart disease and risk for secondary cardiovascular events:more than simply a marker of glomerular filtration rate [J ]. Clin Chem, 2005,51 (2) : 321-327.
5Noto D, Cefalu AB, Barbagallo CM, et al. Cystatin C levels are decreased in acute myocardial infarction:effect of cystatin C G73A gene polymorphism on plasma levels[J]. Int J Cardiol, 2005,101 (2) : 213-217.
6Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease [J]. Am J Cardio, 1983,51 (3) : 606.
7Dharnidharka VR, Kwon C,Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function:a meta-analysis [J]. Am J Kidney Dis,2002,40 (2) :221-226.
8Luc G,Bard JM,Lesueur C,et al. Plasma cystatin-C and development of coronary heart disease:The Prime Study [ J ]. Atherosclerosis, 2006,185 (2) : 375-380.
9Ix JH,Shlipak MG,Chertow GM,et al. Association of cystatin C with mortality,cardiovascular events,and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study [J].Circulation, 2007,115(2) : 173-179.
10Shlipak MG, Fried LF, Crump C,et al. Elevations of inflammatory and proeoagulant biomarkers in elderly persons with renal insufficiency [J]. Circulation,2003,107 ( 1 ): 87-92.
4National Kidney Foundation.K/DOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification[J].Am J Kidney Dis,2002,39(Suppl 2):S1-246.
5Watanabe S,Okra T,Liu J,et al.Serum cystain C level is a marker of end-organ damage in patients with essential hypertension[J].Hypertens Res,2003,26:895-899.
6Singh D,Whooley MA,Ix JH,et al.Association of cystatin C and estimated GFR with inflammatory biomarkers:the Heart and Soul Study[J].Nephrol Dial Transplant,2007,22:1087-1092.
7Lee BW,Ihm SH,Choi MC,etal.The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy[J].Diabetes Res Clin Pract,2007,78:428-434.
9Hojs R,Bevc S,Ekart R,et al.Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease[J].Clin Nephrol,2008,70(1):10-17.
10Dzielinska Z,Januszewica A,Wiecek A,et al.Reduced kidney function estimateed by cystatin C and clinical outcomes in hypertensive patients with coronary artery disease:association with homocysteine and other cardiovascular risk factors[J].Kidney Blood Press Res,2010,33(2):139-148.
